[1]
2026. Influence of the immune system on the successful discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia. Electronic Journal Collection Health. 26, 1 (Jan. 2026), e22317. DOI:https://doi.org/10.25248/reas.e22317.2026.